cellestis-limited CELLESTIS LIMITED CST - Profile and Status | deListed Australia


We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

deListed Australia



Browse Australian delisted companies0-9A BC DE F GH IJ KL MN OP QR ST UV WX YZ
Browse terminated Australian managed funds0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ


Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


Delisted from ASX 30/08/2011


Former (or subsequent) names


Shareholder links

Our website ranking of CST: rating 2
(2 out of 5)


Computershare, Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 3 9415 4000 or 1300 850 505
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

Address: Level 1, Office Tower 2 Chadstone Centre 1341 Dandenong Rd Chadstone, VIC 3148
Tel:  + 61 3 8527 3500 Fax: + 61 3 9568 6623

Date first listed: 24/04/2001
Company Secretary: Mr Brian Manuel
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Research, develop and market QuantiFERON technology products for medical diagnosis and scientific research - the QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses using whole blood samples
delisted at the request of the Company under listing rule 17.11, following confirmation of the implementation of the scheme of arrangement by which QIAGEN Australia Holding Pty Ltd is now the sole shareholder in the Company30/08/2011
we understand Cellestis shareholders received Scheme Consideration of $3.74 per Cellestis share from QIAGEN Australia Holding Pty Ltd and a Special Dividend of $0.06 per Cellestis Share, together representing Total Cash Payments of $3.80 per Cellestis share30/08/2011
the securities of Cellestis Limited (the "Company") will be suspended from quotation at the close of trading today, 10 August 2011, at the request of the Company, following lodgement with ASIC of the court order approving the scheme of arrangement between the Company and its shareholders to effect the acquisition of the Company by QIAGEN Australia Holding Pty Limited10/08/2011
we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - Qiagen Australia Holdings Pty Limited to acquire shares - this corporate event may appear elsewhere in this company record28/07/2011

ASX Announcements (courtesy of ASX)


Your comments

Please read our Terms before viewing comments.


Company Updates

Post your comments here

Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)


    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    Ronald PitcherChairman
    Anthony RadfordManaging Director
    Brian ManuelCFO
    Antonino CatanzaroDirector
    James RothelDirector
    John BennettsDirector

    Date of first appointment, title may have changed.

    Directors & Executives (former)


    Date of first appointment, title may have changed.